Published in Medical Letter on the CDC and FDA, February 10th, 2008
Through DSC127, Derma Sciences will be able to position itself as a key player in the very large...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA